The management of metastatic differentiated thyroid carcinoma.
Sherman
S I
SI
Section of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. sisherma@mdanderson.org
D018263:Adenocarcinoma, Follicular / Q000556:secondary* / Q000628:therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002291:Carcinoma, Papillary / Q000556:secondary* / Q000628:therapy; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D009362:Neoplasm Metastasis / Q000628:therapy*; D011878:Radiotherapy; D013514:Surgical Procedures, Operative; D013954:Thyroglobulin / Q000097:blood; D013964:Thyroid Neoplasms / Q000473:pathology*
D000970:Antineoplastic Agents; D007155:Immunologic Factors; D007457:Iodine Radioisotopes; D013954:Thyroglobulin